Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy
Article Abstract:
HIV patients whose CD4 T cell counts increase to 200 or more in response to antiretroviral therapy can stop taking drugs to prevent Pneumocystis carinii pneumonia (PCP). In a study of 325 such patients, none developed PCP during an average of 13 months after they stopped taking drugs to prevent PCP.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Regional differences in use of antiretroviral agents and primary prophylaxis in 3,122 European HIV-infected patients
Article Abstract:
This study points out that once clinical trials are finished, actual use of drugs designed to protect HIV-infected patients from opportunistic infections may vary widely. It was learned that this is the case across Europe, and guidelines have not been followed.
Publication Name: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Subject: Health
ISSN: 1077-9450
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
HIV Viral Load Response to Antiretroviral Therapy According to the Baseline CD4 Cell Count and Viral Load. (Original Contribution)
Article Abstract:
HIV patients whose CD4 T cell counts are less than 200 may still respond to highly active antiretroviral therapy (HAART), according to a study 3,226 patients. This was true even in patients who had large amounts of virus in their blood.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia: a randomized, placebo-controlled study
- Abstracts: Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia: a randomized, placebo-controlled study. part 2
- Abstracts: Pivotal role of early and sustained infarct vessel patency in patients with acute myocardial infarction. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis
- Abstracts: Localization of endocrine tumors of the pancreas with endoscopic ultrasonography. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT
- Abstracts: Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation ion rheumatoid synovial fluid